Gang Chen

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Lymph Node Metastasis

Tyrosine Kinase

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yaxiong Zhang, Zihong Chen, Yu Liu, Liang Han, Wei Jiang, Qiming Wang, Jianhua Shi, Liqin Lu, Jianying Li, Mingjun Zhang, Yan Huang, Yunpeng Yang, Xue Hou, Li Zhang, Jing Li, Wenfeng Fang, Gang Chen
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis. Cancer medicine 13 (7) (2024)
Yaxiong Zhang, Zihong Chen, Yu Liu, Liang Han, Wei Jiang, Qiming Wang, Jianhua Shi, Liqin Lu, Jianying Li, Mingjun Zhang, Yan Huang, Yunpeng Yang, Xue Hou, Li Zhang, Jing Li, Wenfeng Fang, Gang Chen
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis. Cancer medicine 13 (7) (2024)
Yaxiong Zhang, Zihong Chen, Yu Liu, Liang Han, Wei Jiang, Qiming Wang, Jianhua Shi, Liqin Lu, Jianying Li, Mingjun Zhang, Yan Huang, Yunpeng Yang, Xue Hou, Li Zhang, Jing Li, Wenfeng Fang, Gang Chen
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis. Cancer medicine 13 (7) (2024)
Xiang Chen, Xueyuan Chen, Tingting Liu, Ting Zhou, Gang Chen, Huaqiang Zhou, Yan Huang, Wenfeng Fang, Yunpeng Yang, Ningning Zhou, Likun Chen, Silang Mo, Li Zhang, Yuanyuan Zhao
The maximum tumor growth rate predicts clinical outcomes of patients with small-cell lung cancer undergoing first-line chemotherapy plus immune-checkpoint inhibitor therapy. Cancer medicine (2023)
Bi Jing Xiao, Xiao Xian Sima, Gang Chen, Haimiti Gulizeba, Ting Zhou, Yan Huang
Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy. Cancer medicine (2023)
Jiaqing Liu, Hua-Qiang Zhou, Yaxiong Zhang, Yan Huang, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Gang Chen, Shen Zhao, Xi Chen, Zhonghan Zhang, Jiayi Shen, Wei Xian, Jianhua Zhan, Yuanyuan Zhao, Xue Hou, Yuxiang Ma, Ting Zhou, Hongyun Zhao, Li Zhang
Docosapentaenoic acid and lung cancer risk: A Mendelian randomization study. Cancer medicine 8 (4) (2019)
Zhonghan Zhang, Yaxiong Zhang, Gang Chen, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Fan Luo, Xi Chen, Yuxiang Ma, Yuanyuan Zhao, Jianhua Zhan, Cong Xue, Xue Hou, Ting Zhou, Shuxiang Ma, Fangfang Gao, Yan Huang, Likun Chen, Ningning Zhou, Hongyun Zhao, Li Zhang
Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis. The oncologist 23 (5) (2018)
Shen Zhao, Ting Zhou, Shuxiang Ma, Yuanyuan Zhao, Jianhua Zhan, Wenfeng Fang, Yunpeng Yang, Xue Hou, Zhonghan Zhang, Gang Chen, Yaxiong Zhang, Yan Huang, Li Zhang
Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer. Cancer medicine 7 (9) (2018)
Hua-Qiang Zhou, Wei Xian, Yaxiong Zhang, Gang Chen, Shen Zhao, Xi Chen, Zhonghan Zhang, Jiayi Shen, Shaodong Hong, Yan Huang, Li Zhang
Trends in incidence and associated risk factors of suicide mortality in patients with non-small cell lung cancer. Cancer medicine 7 (8) (2018)
Gang Chen, Xi Chen, Yaxiong Zhang, Fang Yan, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Siyu Miao, Manli Wu, Xiaodan Huang, Youli Luo, Cong Zhou, Run Gong, Yan Huang, Ningning Zhou, Hongyun Zhao, Li Zhang
A large, single-center, real-world study of clinicopathological characteristics and treatment in advanced ALK-positive non-small-cell lung cancer. Cancer medicine 6 (5) (2017)